8V23
Crystal structure of HIV-1 capsid N-terminal domain in the presence of Lenacapavir
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2023-06-20 |
Detector | RDI CMOS_8M |
Wavelength(s) | 1.0003 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 32.218, 44.127, 91.608 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 45.800 - 2.000 |
Rwork | 0.230 |
R-free | 0.28590 |
Structure solution method | MOLECULAR REPLACEMENT |
Data reduction software | XDS (v30jun2023) |
Data scaling software | Aimless (v1.1.12) |
Phasing software | PHASER (v1.1.12) |
Refinement software | REFMAC (v1.1.12) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 45.800 | 2.072 |
High resolution limit [Å] | 2.000 | 2.000 |
Rpim | 0.036 | 0.100 |
Number of reflections | 9274 | 896 |
<I/σ(I)> | 18.82 | 8.99 |
Completeness [%] | 99.4 | 100 |
Redundancy | 6.2 | 6.5 |
CC(1/2) | 0.996 | 0.986 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 290 | 0.17 M Sodium acetate trihydrate, 0.085 M Sodium cacodylate trihydrate pH 6.5, 25.5% w/v Polyethylene glycol 8,000, 15% v/v Glycerol |